iPSC Regenerative Medicine
【Ophthalmology Area】
Development Code |
Indication |
Market |
Pre-clinical test |
Clinical test |
Apply-approve |
On the Market |
Progress Status |
HLCR011 |
Wet AMD |
Japan |
|
|
|
|
Joint development with Sumitomo Dainippon Pharma
Undergoing preparation for clinical trial |
Development Code |
Indication |
Market |
Pre-clinical test |
Phase I Trial |
Phase II Trial |
Phase III Trial |
Apply-approve |
On the Market |
Progress Status |
HLCR012 |
Dry AMD |
US EU |
|
|
|
|
|
|
|
【Liver Disease】
Development Code |
Indication |
Market |
Pre-clinical test |
Clinical test |
Apply-approve |
On the Market |
Progress Status |
HLCL041 |
Metabolic Liver Disease |
Japan |
|
|
|
|
Joint research with Yokohama City University |
【Immuno Oncology】
Development Code |
Indication |
Market |
Pre-clinical test |
Clinical test |
Apply-approve |
On the Market |
Progress Status |
HLCN061 |
Solid Tumors |
Japan |
|
|
|
|
Healios is promoting R&D |
Development Code |
Indication |
Market |
Pre-clinical test |
Phase I Trial |
Phase II Trial |
Phase III Trial |
Apply-approve |
On the Market |
Progress Status |
HLCN061 |
Solid Tumors |
US |
|
|
|
|
|
|
Healios is promoting R&D |
- NK (Natural killer) cells : NK cells are a subset of lymphocytes, a type of white blood cell. NK cells play a central role in a cell mediated defense system that human bodies naturally have, and attack cancer cells and virus-infected cells.
About iPSC Regenerative Medicine
Somatic Stem Cell Regenerative Medicine
Development Code |
Indication |
Market |
Pre-clinical test |
Clinical test |
Apply-approve |
On the Market |
Progress Status |
HLCM051 |
Ischemic Stroke |
Japan |
|
|
|
|
Clinical trial (TREASURE study) ongoing |
HLCM051 |
ARDS |
Japan |
|
|
|
|
Clinical trial (ONE-BRIDGE study) ongoing |
About Somatic Stem Cell Regenerative Medicine